<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04332861</url>
  </required_header>
  <id_info>
    <org_study_id>STU-2018-0028</org_study_id>
    <nct_id>NCT04332861</nct_id>
  </id_info>
  <brief_title>Evaluation of Infection in Obstructing Urolithiasis</brief_title>
  <acronym>eIOU</acronym>
  <official_title>Evaluation of Infection in Obstructing Urolithiasis: A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructing urolithiasis can be life-threatening in the setting of urinary tract infection.&#xD;
      The purpose of this study is to identify and validate risk factors and markers for the&#xD;
      presence of infection and development of sepsis among patients with obstructing urolithiasis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An obstructing stone and suspected urinary tract infection is an indication for drainage of&#xD;
      the renal collecting system. In this setting, decompression with a ureteral stent or&#xD;
      percutaneous nephrostomy (PCN) is associated with decreased mortality and both methods have&#xD;
      similar efficacy. At the time of initial evaluation, it is sometimes uncertain whether&#xD;
      infection is present, resulting in difficult management decisions. It is also difficult to&#xD;
      identify infected patients at greatest risk of developing sepsis, defined as life-threatening&#xD;
      organ dysfunction caused by a dysregulated host response to infection.&#xD;
&#xD;
      There are currently no widely adopted criteria for the accurate diagnosis of infection in the&#xD;
      setting of an obstructing stone. Abnormal vital signs, leukocytosis, and abnormal urinalysis&#xD;
      are relied upon, but these findings are often indeterminate. Most studies to date addressing&#xD;
      this problem have retrospectively evaluated associations of single variables with infection&#xD;
      including pyuria and bacteriuria, or performance of sepsis screening tools such as the&#xD;
      Sepsis-related Organ Failure Assessment (SOFA).&#xD;
&#xD;
      More accurate diagnostic measures for infected obstructing urolithiasis and a better&#xD;
      understanding of its natural history are needed in order to improve patient outcomes. While&#xD;
      early recognition of patients at significant risk of developing sepsis is essential,&#xD;
      treatment of patients who are not clinically infected with antibiotics and decompression&#xD;
      procedures is unnecessarily morbid. Therefore, the investigators aim to develop and validate&#xD;
      diagnostic criteria to predict development of life-threatening infection in a prospective&#xD;
      observational fashion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 3, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary tract infection (positive urine culture)</measure>
    <time_frame>Within 24-72 hours of initial clinical and laboratory evaluation</time_frame>
    <description>Urinary tract infection, defined as a positive urine culture</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intensive care unit admission and/or death due to sepsis during inpatient encounter</measure>
    <time_frame>On average within 24-72 hours after initial clinical and laboratory evaluation</time_frame>
    <description>Intensive care unit admission and/or death secondary to sepsis, occurring during the inpatient incounter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacteremia (at least one positive blood culture)</measure>
    <time_frame>Within 24-72 hours of initial clinical and laboratory evaluation</time_frame>
    <description>Bacteremia, defined as at least one positive blood culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pyonephrosis (drainage of pus from the involved kidney) during inpatient encounter</measure>
    <time_frame>On average within 24-72 hours after initial clinical and laboratory evaluation</time_frame>
    <description>Pyonephrosis, defined as drainage of pus from the involved kidney at any point during the inpatient encounter</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Kidney Stone</condition>
  <condition>Kidney Calculi</condition>
  <condition>Urinary Tract Obstruction</condition>
  <condition>Infection</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Prospective observational cohort</arm_group_label>
    <description>For data analysis, the cohort will be subdivided as follows:&#xD;
Identification and Validation cohorts&#xD;
Patients with and without complicating factors&#xD;
Patients with and without measured inflammatory marker levels</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Initial clinical and laboratory evaluation</intervention_name>
    <description>Initial evaluation, prior to administration of any antibiotics if possible, includes history, physical exam, and labs including:&#xD;
Urinalysis&#xD;
Urine culture&#xD;
Blood cultures&#xD;
Complete blood count with differential&#xD;
Comprehensive metabolic panel&#xD;
Lactate&#xD;
Procalcitonin&#xD;
Other inflammatory markers</description>
    <arm_group_label>Prospective observational cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Excess/discarded blood specimens&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be men and women presenting to the emergency department or already admitted&#xD;
        to the hospital with a new diagnosis of obstructing urolithiasis on computed tomography&#xD;
        (CT).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women 18 and older&#xD;
&#xD;
          -  Acute presentation of obstructing urolithiasis diagnosed on CT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Indwelling nephrostomy tubes or ureteral stents&#xD;
&#xD;
          -  Staghorn calculi or evidence of xanthogranulomatous pyelonephritis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jodi Antonelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Margaret S Pearle, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center Clements University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016 Oct;196(4):1153-60. doi: 10.1016/j.juro.2016.05.090. Epub 2016 May 27.</citation>
    <PMID>27238616</PMID>
  </reference>
  <reference>
    <citation>Borofsky MS, Walter D, Shah O, Goldfarb DS, Mues AC, Makarov DV. Surgical decompression is associated with decreased mortality in patients with sepsis and ureteral calculi. J Urol. 2013 Mar;189(3):946-51. doi: 10.1016/j.juro.2012.09.088. Epub 2012 Sep 24.</citation>
    <PMID>23017519</PMID>
  </reference>
  <reference>
    <citation>Pearle MS, Pierce HL, Miller GL, Summa JA, Mutz JM, Petty BA, Roehrborn CG, Kryger JV, Nakada SY. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol. 1998 Oct;160(4):1260-4.</citation>
    <PMID>9751331</PMID>
  </reference>
  <reference>
    <citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.</citation>
    <PMID>26903338</PMID>
  </reference>
  <reference>
    <citation>Abrahamian FM, Krishnadasan A, Mower WR, Moran GJ, Talan DA. Association of pyuria and clinical characteristics with the presence of urinary tract infection among patients with acute nephrolithiasis. Ann Emerg Med. 2013 Nov;62(5):526-533. doi: 10.1016/j.annemergmed.2013.06.006. Epub 2013 Jul 11.</citation>
    <PMID>23850311</PMID>
  </reference>
  <reference>
    <citation>Cheung F, Loeb CA, Croglio MP, Waltzer WC, Weissbart SJ. Bacteria on Urine Microscopy Is Not Associated with Systemic Infection in Patients with Obstructing Urolithiasis. J Endourol. 2017 Sep;31(9):942-945. doi: 10.1089/end.2017.0157. Epub 2017 Jun 27.</citation>
    <PMID>28558478</PMID>
  </reference>
  <reference>
    <citation>Fukushima H, Kobayashi M, Kawano K, Morimoto S. Performance of Quick Sequential (Sepsis Related) and Sequential (Sepsis Related) Organ Failure Assessment to Predict Mortality in Patients with Acute Pyelonephritis Associated with Upper Urinary Tract Calculi. J Urol. 2018 Jun;199(6):1526-1533. doi: 10.1016/j.juro.2017.12.052. Epub 2017 Dec 29.</citation>
    <PMID>29291417</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2020</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Jodi Antonelli</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Kidney Stone</keyword>
  <keyword>Kidney Calculi</keyword>
  <keyword>Urinary Tract Obstruction</keyword>
  <keyword>Infection</keyword>
  <keyword>Sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

